ERBB2 and carcinoma: Interestingly, we analyzed the expression of a large panel of immunohistochemical markers and only SOX10 was more frequently expressed in ERBB2‐amplified ILBC, a marker that is typically positive in triple‐negative NST and non‐NST carcinomas.